Clinical Trial Update: Induction, Consolidation and Intensification Therapy for Patients Younger Than 66 Years With Previously Untreated CD33 Positive Acute Myeloid Leukemia (AML) [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluating induction, consolidation, and intensification therapy for patients younger than 66 with previously untreated CD3…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: University Hospital, Udine, Italy | Conditions: Acute Myeloid Leukemia | Phase 2, Phase 3 | Status: COMPLETED